Disc Medicine, Inc. IRON
65.24
(1.20)
(1.81%)
as of 25 Sep
- Market cap
- $2.6B
- P/E
- 0.0×
Follow IRON
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
24.14 | 24.00 | 21.94 | 23.45 |
+8 more quarters Free account |
Net Debt/EBITDA |
10.06 | 9.94 | 11.12 | 8.46 | |
Debt/Assets |
8.07% | 3.91% | 3.61% | 4.59% | |
Debt/Equity |
0.09 | 0.04 | 0.04 | 0.05 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.74 | 0.98 | 0.72 | 0.77 | |
Capex/Depreciation |
0.00 | 0.00 | 0.01 | 0.02 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(1.14) | (1.62) | (1.23) | (1.36) | |
Cash per Share |
18.55 | 18.97 | 22.42 | 17.51 | |
Shareholders Equity per Share |
16.65 | 17.89 | 20.96 | 16.30 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
16.65 | 17.89 | 20.96 | 16.30 | |
Free Cash Flow |
(44.20) | (62.24) | (43.32) | (47.82) | |
Working Capital |
702.40 | 716.31 | 767.26 | 600.42 | |
Capital Expenditures |
— | — | (0.02) | (0.03) | |
Net Current Asset Value |
641.85 | 685.67 | 736.85 | 570.10 | |
| Other line items | |||||
Quick Ratio |
23.64 | 23.45 | 21.59 | 23.03 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.14) | (1.62) | (1.23) | (1.36) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
6.60 | 9.23 | 8.48 | 5.41 | |
Average Assets |
700.07 | 729.74 | 651.83 | 562.80 | |
Average Common Equity |
629.16 | 674.40 | 591.71 | 520.68 | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates